| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
disease | 0.610 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.600 | None | 0.964 | 1 | 0 | 1995 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
TNF receptor superfamily member 10a | 0.521 | 0.731 | 5.1E-15 |
|
disease | 0.520 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
mucin 2, oligomeric mucus/gel-forming | 0.486 | 0.808 | 9.4E-10 |
|
disease | 0.300 | None | 0.938 | 2 | 0 | 1991 | 2018 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1999 | 2018 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
disease | 0.290 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
Nanog homeobox | 0.531 | 0.654 | 0.72 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
trefoil factor 3 | 0.518 | 0.885 | 1.6E-02 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2008 | 2015 | ||||||||
|
NAD(P)H quinone dehydrogenase 1 | 0.434 | 0.885 | 1.2E-09 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2000 | 2019 | ||||||||
|
BCL2 associated agonist of cell death | 0.553 | 0.769 | 4.6E-03 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2004 | 2015 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
lipocalin 2 | 0.405 | 0.885 | 1.1E-09 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2010 | 2018 | ||||||||
|
apolipoprotein B mRNA editing enzyme catalytic subunit 1 | 0.647 | 0.385 | 1.7E-08 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 1998 | 2002 | ||||||||
|
inhibitor of nuclear factor kappa B kinase subunit beta | 0.506 | 0.846 | 0.99 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
choline kinase alpha | 0.615 | 0.615 | 0.23 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 1999 | 2013 | ||||||||
|
regenerating family member 1 alpha | 0.467 | 0.846 | 1.3E-05 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 1990 | 2008 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2010 | 2018 | ||||||||
|
prostaglandin E receptor 3 | 0.601 | 0.731 | 0.37 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2004 | 2011 | ||||||||
|
apoptotic peptidase activating factor 1 | 0.525 | 0.769 | 9.6E-06 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
C-C motif chemokine ligand 3 | 0.460 | 0.885 | 0.35 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 |